Temple Bar: Investing through the pessimism

By Ian Lance, co-portfolio manager

Every time I visit my mother, she asks me why the stock market is doing so well when the current government appears determined to hamper the economy by raising taxes, increasing the cost of employing staff, driving up energy prices or just generally getting in the way of business by adding layers of bureaucracy and regulation.

I suspect she is not alone in wondering this. Many Temple Bar shareholders may feel the same unease, with political and economic headlines remaining relentlessly gloomy. The purpose of this letter, therefore, is to explain why such headlines can often be a poor guide to long-term investment outcomes – and explore why periods of widespread pessimism can, in fact, create opportunity rather than destroy it.

Macroeconomic forecasting is not a reliable investment strategy

Very few investors can predict with confidence when recessions will occur, how severe they will become or how long they will last. The same is true of monetary policy. Accurately forecasting changes in central bank behaviour, and then successfully judging how markets will respond to them, is extraordinarily difficult.

If perfect foresight were reliably achievable, macroeconomic forecasting would be a powerful investment tool. In practice, this is rarely possible. Warren Buffett famously advised against it as an investment strategy and advocated exploiting the over-reaction of others to the swings of the economic cycle.

“We will continue to ignore political and economic forecasts which are an expensive distraction for many investors and businessmen. Thirty years ago, no one could have foreseen the huge expansion of the Vietnam War, wage and price controls, two oil shocks, the resignation of a president, the dissolution of the Soviet Union, a one-day drop in the Dow of 508 points, or treasury bill yields fluctuating between 2.8% and 17.4%. But surprise: None of these blockbuster events made even the slightest dent in Ben Graham’s investment principles. Nor did they render unsound the negotiated purchases of fine businesses at sensible prices. Imagine the cost to us, if we had let a fear of unknowns cause us to defer or alter the deployment of capital. Indeed, we have usually made our best purchases when apprehensions about some macro events were at a peak. Fear is the foe of the faddist, but the friend of the fundamentalist.”
Source: Warren Buffett, Berkshire Hathaway Letter to Shareholders, March 1995

Economic events impact share prices more than fundamentals

We believe that our ability to add value as investors comes from focusing on where a company’s profits are likely to be over the long term (five or more years), rather than the short-term earnings momentum that most other investors prioritise (often just the next quarter). When we buy equity in a business, we are buying a share of a very long-term stream of future cashflows. From that perspective, a temporary reduction in profits over a year or two does very little to alter the long-run intrinsic value of that business.

As we explored in our January 2022 newsletter, this can be illustrated using a simple net present value (NPV) analysis, which shows how different earnings outcomes affect a company’s intrinsic value. As shown in charts one and two below, the key point is that temporary earnings declines typically have a surprisingly modest impact on long-term value, provided the underlying earnings power of the business remains intact.

Even in a severe recession scenario, where profits are sharply reduced for a period, the impact on intrinsic value is limited. It is only when earnings suffer permanent impairment, and fail to recover to prior levels, that long-term value is significantly affected.

Despite this, many investors have a tendency towards extrapolation and over-reaction to short-term news flow and earnings trends. In doing so, they can create the very mis-pricings that longer-term investors like us are seeking to identify and capture.

The difference between investment and speculation

In essence, this distinction explains the difference between investment and speculation. An investor recognises that buying equity means owning a share of a long stream of future cashflows and seeks to take advantage of situations where share prices fall well below a conservative estimate of intrinsic value. From this perspective, a period of weaker earnings does not normally alter the long-term value of a business materially.

A speculator, by contrast, is trying to guess where share prices are going over the next few weeks and, hence, is playing John Maynard Keynes’s famous ‘beauty contest’ – seeking to anticipate how others will feel about these stocks in a few weeks’ time. The problem with this approach is that sentiment can be a fickle mistress and can change quickly and unpredictably.

“The most realistic distinction between the investor and speculator is found in their attitude toward stock-market movements. The speculator’s primary interest lies in anticipating and profiting from market fluctuations. The investor’s primary interest lies in acquiring and holding suitable securities at suitable prices.”
Source: Benjamin Graham, The Intelligent Investor, 1949

Valuation, mispricing and where opportunity may lie

Periods of heightened economic uncertainty often lead investors to favour perceived stability and short-term predictability over longer-term value. When headlines are gloomy, many market participants gravitate towards companies whose earnings appear more resilient, even if that resilience is already fully reflected in valuations.

At the same time, businesses whose profits are more sensitive to the economic cycle are frequently marked down aggressively, regardless of their long-term prospects. This explains why several stocks in the portfolio, including media businesses WPP and ITV, are trading on 4-7% dividend yields and low price-to-earnings ratios (P/E). These valuations reflect the fact that most investors would currently rather sell these stocks than buy them.

We also include below a measure of price-to-normalised-earnings (P/NE), which reflects our assessment of a company’s underlying earnings power in a more typical year. This is important because, as explained earlier, near-term earnings can be depressed in a downturn, making conventional P/E ratios appear misleadingly high. Looking through this allows us to identify businesses whose long-term value – unaffected by the shorter-term earnings impact – is being under-appreciated by the market.  

This valuation gap is not a coincidence. It reflects the behavioural tendencies described earlier – extrapolating short-term weakness, over-reacting to uncertainty and paying a premium for perceived stability. As Keynes observed nearly a century ago, it is precisely these fluctuations that create opportunities for patient, disciplined investors willing to look beyond the prevailing mood.

“It is largely the fluctuations which throw up the bargains and the uncertainty due to the fluctuations which prevents other people from taking advantage of them.”
Source: John Maynard Keynes, General Theory of Employment, Interest and Money, 1936

Conclusion: discomfort, discipline and continued opportunity

Periods of heightened uncertainty tend to magnify short-term share price movements far more than they alter the long-term prospects of businesses. When investors allow media headlines and market sentiment to dominate their thinking, valuations can become disconnected from underlying fundamentals. We believe that for those willing to remain focused on long-term value, this divergence is not a threat – it’s an opportunity.

We understand that owning or buying cyclically-exposed businesses today may feel uncomfortable. Yet it has been our experience that it is precisely this discomfort that creates the conditions for long-term outperformance. As another very talented investor once said to me, “Some of my greatest investments made me feel physically sick at the time I put them on”.

In one of his regular investment memos, Howard Marks, co-founder and now co-chairman of Oaktree Capital, makes the same point:

“Most great investments begin in discomfort. The things most people feel good about – investments where the underlying premise is widely accepted, the recent performance has been positive, and the outlook is rosy – are unlikely to be available at bargain prices. Rather, bargains are usually found among things that are controversial, that people are pessimistic about, and that have been performing badly of late.”
Source: Oaktree Capital, April 2014

Despite the headlines, recent performance has been rewarding for Temple Bar shareholders, but this has not removed the opportunity set that our disciplined, valuation-led investment approach seeks to capture. Indeed, if anything, today’s pervasive economic pessimism may be helping to lay the foundations for the next leg of performance for patient UK investors to enjoy, as short-term anxiety once again creates long-term opportunity.

Thank you for your continued support.


Past performance is not a guide to the future. The price of investments and the income from them may fall as well as rise and investors may not get back the full amount invested. Forecasts and estimates are based upon subjective assumptions about circumstances and events that may not yet have taken place and may never do so.

No investment strategy or risk management technique can guarantee returns or eliminate risks in any market environment. Nothing in this document should be construed as advice and is therefore not a recommendation to buy or sell shares. Information contained in this document should not be viewed as indicative of future results. The value of investments can go down as well as up.

This article is issued by RWC Asset Management LLP (Redwheel), in its capacity as the appointed portfolio manager to the Temple Bar Investment Trust Plc. Redwheel is authorised and regulated by the UK Financial Conduct Authority and the US Securities and Exchange Commission.

The statements and opinions expressed in this article are those of the author as of the date of publication.

Redwheel may act as investment manager or adviser, or otherwise provide services, to more than one product pursuing a similar investment strategy or focus to the product detailed in this document. Redwheel seeks to minimise any conflicts of interest, and endeavours to act at all times in accordance with its legal and regulatory obligations as well as its own policies and codes of conduct.

This document is directed only at professional, institutional, wholesale or qualified investors. The services provided by Redwheel are available only to such persons. It is not intended for distribution to and should not be relied on by any person who would qualify as a retail or individual investor in any jurisdiction or for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to local law or regulation.

The information contained herein does not constitute: (i) a binding legal agreement; (ii) legal, regulatory, tax, accounting or other advice; (iii) an offer, recommendation or solicitation to buy or sell shares in any fund, security, commodity, financial instrument or derivative linked to, or otherwise included in a portfolio managed or advised by Redwheel; or (iv) an offer to enter into any other transaction whatsoever (each a Transaction). No representations and/or warranties are made that the information contained herein is either up to date and/or accurate and is not intended to be used or relied upon by any counterparty, investor or any other third party. Redwheel bears no responsibility for your investment research and/or investment decisions and you should consult your own lawyer, accountant, tax adviser or other professional adviser before entering into any Transaction.

Dr. Martens reports declining revenue amid strategic shift

Dr. Martens shares fell on Tuesday after reporting a 2.7% decline in constant-currency revenue to £253 million for the 13 weeks ended 28 December 2025, as the footwear brand continues its strategic pivot away from promotional activity.

The company’s year-to-date group revenue fell 0.7% on a constant currency basis to £580 million, reflecting what management described as a deliberate focus on improving revenue quality rather than volume.

Shares were 8% lower at the time of writing on Tuesday as the group reported falling sales alongside a strategy shakeup that will reduce the level of promotional activity.

Adam Vettese, market analyst for eToro, explained taht: “Dr Martens’ Q3 update shows the bootmaker lacing up for a turnaround, but it’s a slow jog not a sprint. Group revenue dipped 3.1% in the festive quarter amid a deliberate pullback on discounts, leaving full year outlook broadly flat, prioritising profit quality over volume chases.

“Some positive signs are there with full price direct to consumer up 2% year to date with Americas holding firm at 2% growth, wholesale up 9.5%, and smart moves like shifting Vietnam production to blunt Trump tariffs. Yet Europe’s weak demand and reliance on new categories like Buzz and Zebzag mean execution risks loom large.”

Direct-to-consumer weakness

The quarter saw a stark divergence between sales channels. Wholesale revenue climbed 9.5% in constant currency terms, whilst direct-to-consumer (DTC) revenue dropped 6.5%, as the company reduced clearance activity and adopted a more disciplined promotional stance.

Despite the overall revenue decline, Dr. Martens highlighted that full-price DTC revenues rose 2% year-to-date, with particularly strong performance in the Americas region.

The EMEA region proved most challenging, with revenue declining 6% in constant currency during Q3. The company attributed this to a channel shift towards wholesale partners during the promotional season, particularly in Germany and the UK, which together account for over half of EMEA revenue. Wholesale revenues in the region increased 13%, whilst DTC fell 12%.

Americas delivered 2% revenue growth, with year-to-date growth of 4.5% in constant currency. The APAC region saw overall revenue decline 3%, though the company noted “continued strong growth” in South Korea and expressed satisfaction with growth in full-price DTC revenues following reduced promotional activity.

Outlook

Management expects full-year revenue to be broadly flat on a constant currency basis, maintaining its focus on profitability over volume growth. The company confirmed it remains “comfortable with market expectations for FY26 PBT”, which will deliver “significant year-on-year PBT growth”.

AIM movers: Positive news for Thor Explorations from Senegal and Nativo Resources appoints mining contractor

11

Shares in Goldstone Resources (LON: GRL) have risen a further 41.2% to 1.2p following last week’s announcement that it is raising £2m at 1p/share, which was then a premium to the market price. The share price has trebled in the past week. The cash will fund exploration at the Homase mine in Ghana to expand the JORC resource and to evaluate other gold projects, including one in Sierra Leone.

Nativo Resources (LON: NTVO) has appointed Constructora e Inversiones Andina Kuboc C&P SAC as mining contractor for the Bonanza gold mine in Peru. The focus is improving the mine infrastructure. This brings gold production nearer and first gold sales could be in March. Early production of 50-90 tonnes per month is targeted. The share price increased 32% to 0.66p.

Andrada Mining (LON: ATM) has revealed good surface sampling results from Lithium Ridge in Namibia. Multiple samples had grades exceeding 4% Li2O. There is also tin and tantalum mineralisation. The share price improved 3.53% to 4.4p.

Thor Explorations (LON: THX) has announced a pre-feasibility study for the Douta gold project in Senegal and first production could be in 2028. The pre-tax project NPV5% is $908m at a long-term gold price of $3,500/ounce, while the post-tax NPV5% is $633m. This assumes 100% ownership. Payback of initial capital investment of $254m could be less than one year.  There could be one million ounces of gold produced over nearly 13 years. The resource can be extended. Thor Explorations is buying out its 30% joint venture partner in the Douta West permit joint venture Birma Resources for an initial $1.5m. The share price gained 5.49% to 96p.

FALLERS

Contract proteomics services provider Proteome Sciences (LON: PRM) has raised £840,000 at 1.75p/share and a retail offer could raise up to £60,000. The cash will be used to increase Tandem Mass Tags plexing rate from 32x to 96x and introduce novel Solvent Shift chemoproteomic workflows. It will also go towards launching a new range of DXT isotopic plex tags and concluding a DXT licence, will increasing capacity in San Diego. The share price slumped 31.9% to 2.2p.

Botswana Diamonds (LON: BOD) been awarded eight prospecting licences in north west Botswana. They have been chosen for prospectivity for copper, gold, silver and other critical minerals. The company is speaking with potential joint venture partners. The share price dipped 6.56% to 0.285p.

Active Energy Group (LON: AEG) has entered a non-binding memorandum of understanding with two existing UAE-based partners to form a joint venture for Bitcoin mining in the UAE. One partner has digital infrastructure expertise and the other has relationships with hosting clients and sales expertise. The share price fell 9.76% to 0.0925p.

Stephen Diggle has stepped down from the board of Oxford BioDynamics (LON: OBD) after nearly a decade. He is also a director of Proteome Sciences and controls Vulpes Investment Management, which owns 14.4% of Oxford BioDynamics and will nominate another director for the EpiSwitch 3D genomics platform developer. The share price slipped 3.7% to 0.26p.

Avon Technologies: offering a strong platform, expanding horizons and significant growth

This coming Friday, 30th January, will see Avon Technologies (LON:AVON), the personal protection equipment specialists, issue a Trading Update ahead of holding its AGM that day. 
Based in Melksham, Wiltshire, the £603m-capitalised group, is a world leader in mission-critical protection equipment. 
Even though the group’s shares have risen over 40% since my April 2025 feature, this week’s statement should be even more positive following the group’s guidance on current year trading. 
It is looking for high single-digit re...

FTSE 100 range-bound as gold and silver soar to record highs

The FTSE 100 was range-bound on Monday as investors navigated geopolitical risks and rising worries about another US government shutdown.

London’s leading index was trading three points higher at 10,146 at the time of writing after trading in a range between 10,170 and 10,127 in early trade.

The FTSE 100’s weighting towards precious metals and defensive sectors helped it outperform European indices as the gold price broke to fresh record highs above $5,000 per oz buoyed by fresh concerns about a US government shutdown.

“There may not be any big geopolitical news to rival last week’s Greenland drama, but internal tensions in the US are helping to keep precious metals prices elevated,” said AJ Bell investment director Russ Mould.

“Gold has moved through $5,000 for the first time – showing investors are still seeking out the traditional haven for some insurance against what remains a febrile backdrop.

“In less than 18 months bullion has more than doubled in value – buoyed by central bank demand, global turmoil, dollar weakness, and the diminished appeal of other popular defensive assets.”

Silver was not left behind by the precious metals rally and smashed through $100 for the first time to trade at $108 at the time of writing.

Fresnillo shares were unsurprisingly at the top of the FTSE 100 leaderboard at the time of writing, with gains of 3%.

Fresnillo shares have doubled since the middle of November, trading just shy of 4,400p at the time of writing. The silver miner started 2024 priced at around 620p. It’s also the second-best performer year to date in 2026, with gains of 30%.

Gold miner Endeavour Mining was 2.9% higher, while diversified miners Antofagasta and Anglo American joined the rally with gains in excess of 2%.

Despite strength in miners, there was plenty of weakness elsewhere that prevented the index from moving materially higher.

3i Group lost around 4% after analysts at RBS cut their rating to underweight, while Barclays reduced its price target.

Autotrader’s downtrend continued with the share price breaking down by over 3% to 550p – the lowest level since 2023.

Experian and Reckitt Beckiser where among other names that saw selling pick up on Monday after a poor week last week.

Harena Rare Earths shares jump on positive PFS

Harena Rare Earths shares jumped on Monday after announcing a pre-feasibility study (PFS) for its Ampasindava rare earth project in Madagascar, confirming strong technical and economic viability for the ionic clay deposit.

Harena Rare Earths, formerly known as Citius Resources, released the PFS after securing 100% ownership of the project last year.

The PFS outlines a 20-year heap leach operation producing approximately 71,000 tonnes of total rare earth oxide, with annual production of 4,000 tonnes TREO, including 1,700 tonnes of critical magnetic rare earth oxides (NdPr + DyTb).

The study, compiled with support from global engineering group SGS, estimates pre-production capital costs of $142 million, including a 25% allowance for EPCM and funding costs. The project is designed for a plant throughput of 5 million tonnes per annum at an average grade of 1,500 ppm TREO.

Using long-term analyst pricing, the project demonstrates robust economics with a pre-tax NPV10 of $343.7 million and an internal rate of return (IRR) of 34%.

Post-tax NPV10 stands at $249.6 million with a 30% IRR and four-year payback period. Life-of-mine free cashflow is projected at $1.0 billion post-tax.

These are all very attractive numbers, and Harena shares reacted accordingly, rising 20% on Monday.

Under current consensus pricing scenarios, the financial metrics improve significantly, with pre-tax NPV10 reaching $616.1 million and undiscounted life-of-mine free cashflow of $2.6 billion post-tax.

“The completion of the PFS represents a significant step forward for Harena and the Ampasindava Project. With significant previous investment in resource development, process testwork and environmental programs, we have an excellent understanding of the Ampasindava Project where we can now further optimise the asset as we move into the final piloting and studies phase,” said Allan Mulligan, Executive Technical Director of Haren.

“The Ampasindava Project hosts a world-class scale ionic absorption rare earths mineralisation, particularly amenable to low cost and high yield recoveries. The sustainable and rapid remediation heap leach extraction model will serve to enhance the local, regional and national economy with no lasting impacts on the environment.

“Our confidence in the results of the PFS and the underlying PFS process more broadly is based on the enormous previous works and current understanding of the orebody, and the inclusion of the Proof-of-Concept plant in 2026 will allow a smooth and organised mobilisation into construction with reduced start up risk.”

Grainger joint venture acquires 195-Home Build-to-Rent scheme in Chiswick

Grainger, the UK’s largest listed residential landlord, has announced that its joint venture with Places for London has agreed to forward fund and acquire a 195-home build-to-rent development in West London.

Connected Living London (CLL), the partnership between Grainger and Places for London, the property arm of Transport for London, will acquire the scheme at Chiswick Reach on Bollo Lane. The development will be built by Barratt Redrow, marking Grainger’s first build-to-rent collaboration with a major UK housebuilder.

The £68.4 million purchase price will be split 51:49 between Grainger and Places for London in line with the CLL structure. The development is expected to generate returns within Grainger’s target range for London schemes, with the company also receiving asset management fees.

The scheme has secured detailed planning consent and Gateway 2 approval from the Building Safety Regulator. It will deliver 195 new build-to-rent homes, including 95 discounted market rent properties, alongside 4,299 sq ft of commercial space and 5,499 sq ft of internal amenity facilities for residents, featuring co-working space and a gym.

“We are pleased to announce this strategic milestone in our partnership with Places for London, a new scheme in our JV’s pipeline with construction commencing imminently, delivering 195 high quality rental homes in a well-connected West London location,” said Helen Gordon, Chief Executive of Grainger.

“Working alongside Barratt Redrow on this project represents an exciting development in our approach to delivery partners, opening potential new avenues for collaboration with major housebuilders as we continue to expand our build-to-rent portfolio across the UK.”

Located on former railway land, Chiswick Reach sits an eight-minute walk from both Chiswick Park station on the District Line and South Acton Overground station

S4 Capital shares surge as profit guidance improves

S4 Capital shares jumped on Monday after reporting fourth-quarter trading ahead of its revised guidance, with the advertising group expecting to exceed the current market consensus for both net revenue and operational EBITDA for the full year.

The company anticipates full-year net revenue of approximately £664 million, representing a like-for-like decline of around 8.5%.

However, the operational EBITDA margin is expected to reach circa 12%, delivering operational EBITDA of roughly £75 million, surpassing the consensus forecast. Investors cheered the update, with shares jumping by more than 20% amid a challenging backdrop for advertising groups.

The introduction of AI is shaking up the industry, and shareholders will be pleased to see S4 successfully navigating the new environment.

The group said it has achieved a substantial improvement in its financial position and Net debt is projected to come in significantly below the current consensus of £133 million and beneath the previously indicated range of £100-140 million.

Consequently, the net debt to operational EBITDA ratio at year-end 2025 is expected to be approximately 1.1x, well below both the current consensus of 1.8x and the company’s target of 1.5x.

“Good to see both delivery beyond revised net revenue and operational EBITDA guidance and the significant improvement in liquidity,” said Sir Martin Sorrell, Executive Chairman of S4 Capital.

“However, there is still much more to be done around net revenue and margin growth in 2026 and beyond which we will cover with the 2025 results presentation in March. The recommended 1p final dividend is an indication of the Board’s confidence in continued improvement. In an increasingly volatile world, clients continue to carefully assess where they should expand geographically and how they can apply new technologies such as AI, Blockchain and Quantum to increasing efficiency.”

Director deals: Touchstar recovery potential

Touchstar (LON: TST) chief executive Lynden Jones bought 7,804 shares at 62p each and 10,000 shares at 65.6p each. He owns 17,804 shares.
Lynden Jones was appointed chief executive in July. He has worked at Touchstar for 14 years.
Business
These purchases follow the trading statement in December when Touchstar admitted it would not meet expectations for 2025 In 2025, revenues will be around £6.7m, compared with the forecast of £8m, and there will be a small pre-tax profit. There will be exceptional costs of £1.45m for restructuring and software impairment. Cash will be £2m at the end of the ye...

Aquis weekly movers: ProBiotix Health increases sales and order book

Cardiometabolic health products developer ProBiotix Health (LON: PBX) increased sales by 45% to £2.72m in 2025 and reduced the loss. During the year, ProBiotix entered the Korean market and submitted applications for two new clinical trials. There was £1.27m in the bank at the end of 2025. The order book is worth £1.3m. The business has been structured to cope with further growth. There will be a focus on growth in Asia Pacific. In Europe, the company is seeking to substitute its LP LDL product for Monacolin K as a cholesterol lowering ingredient in supplements. There are opportunities in the US, but they could be delayed by the trade background. The share price increased 22.6% to 9.5p.

Pulsar Helium (LON: PLSR) has issued a further 145,434 consideration shares to Aquis-quoted Oscillate (LON: SRVL) as part of the deal to acquire Quantum Hydrogen. This takes the stake to 80% with an option to acquire the rest for $400,000 in shares issued in five equal instalments. The Oscillate share price improved 10.7% to 0.415p.

Astrid Intelligence (LON: ASTR) has acquired TaoFi, which provides transactional and liquidity services that are essential to the operation of the Bittensor ecosystem. This strengthens the company’s position in protocol-level services. The consideration was paid in TAO tokens. The share price gained 7.27% to 0.1475p.

Connecting Excellence (LON: XCE) has received settlement of 10 Bitcoin for the first XCE BTC Bond, issued on 31 December 2025 with a BTC price of £65,104.26. the company has 51.35988275 Bitcoin. The share price rose 2.17% to 2.35p.

FALLERS

Bitcoin investor Stack BTC (LON: STAK), formerly Kasei Digital Assets, returned £3.5m to shareholders and that was the major reason behind the 84.6% decline in the share price to 2p.

Ethereum and technology investment company Ethtry (LON: ETHY) is seeking to develop activities in quantum technology, AI and energy transition services. It has bought 500 Ethereum at £2,412 each. A partnership has been secured with AMINA Bank, which will provide access to regulated banking infrastructure and digital asset services. The share price dropped by one-fifth to 0.22p.

Ajax Resources (LON: AJAX) has entered newly negotiated terms for the purchase of the Paguanta project in Chile. The initial payment is $50,000 in cash $350,000 of shares at 25p each. Deferred consideration is $500,000 on proved reserve exceeding 25 million tonnes at more than 5% zinc equivalent and/or $500,000 on proved reserve exceeding five million tonnes of copper. The share price fell 15.6% to 8.125p.

Bitcoin investor and wed development company The Smarter Web Company (LON: SWC) has bought ten Bitcoin at £67,210 each, taking its holding to 2,674 Bitcoin at an average price of £82,800 each. The total value is £221.4m. The share price slipped 14% to 49p. The company is moving to the Main Market on 3 February.

Shares in Valereum (LON: VLRM) returned from suspension 10% lower at 11.25p. A share subscription agreement has been signed with Quorium Global Photonics (QGP), which will subscribe for 243.5 million shares. There is a lock-in agreement until the shares are listed on Nasdaq or New York Stock Exchange, except for 1.44% of the shares each month. In return Valereum will receive $200,000 of medium term notes with an annual coupon of 7.95%. That will generate $15.9m/year for five years. A $1bn bank facility is provided for. There will be $200,000 in fees paid to QGP, which will also receive warrants. Guild Financial Advisory has been appointed corporate adviser

Sulnox Group (LON: SNOX) has obtained another patent in South Africa. This is for an improved oil/water separation methodology for its emulsification products. Sulnox Group has issued 1.4 million shares to Eastern Pacific Shipping Pte Ltd based on the volume of Sulnox Eco it bought. The share price decreased 3.7% to 65p.

Brewer Shepherd Neame (LON: SHEP) says beer volumes fell 6.6% in the first half, while own beer volumes slipped 11.6%. like-for-like pub sales were 4.5% ahead following a strong Christmas period. Tenanted pubs income was 3.1% higher. The interim results will be announced on 18 March. The share price slid 3.41% to 495p.

Maiden figures from Delta Gold Technologies (LON: DGQ) show an interim loss of £126,000 with no revenues. This is to October 2025, so it is before the quantum computing company joined Aquis, raising £2.5m at 10p/share. There is a sponsored research agreement with the University of Toronto. The share price dipped 1.94% to 25.25p.